Allocation concealment and blinding: When ignorance is bliss

Medical Journal of Australia

Volumn 182, Issue 2, 2005, Pages 87-89

  Forder, Peta M ^a   Gebski, Val J ^a   Keech, Anthony C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; HYPOCHOLESTEROLEMIC AGENT; PLACEBO;

ARTICLE; AWARENESS; CARDIOVASCULAR DISEASE; CLINICAL STUDY; CLINICAL TRIAL; COMMON COLD; DATA ANALYSIS; GASTRITIS; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; METHODOLOGY; OPEN STUDY; OUTCOMES RESEARCH; PEPTIC ULCER; PHYSICIAN; RANDOMIZATION; RISK ASSESSMENT; STOMACH EROSION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 12444252181     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06584.x     Document Type: Article

References (13)

1. Altman DG, Schulz KF, Moher D, et al. for the CONSORT Group. The revised CONSORT statement for reporting randomised trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
2. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002; 359: 614-618.
3. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002; 359: 696-700.
4. Sackett DL. Turning a blind eye - why we don't test for blindness at the end of our trials [letter]. BMJ 2004; 328: 1136.
5. Ioannidis JPA, Polycarpou A, Ntais C, Pavlidis N. Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time. Eur J Cancer 2003; 39: 2278-2287.
6. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomisation from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994; 272: 125-128.
7. Dickinson K, Bunn F, Wentz R, et al. Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 2000; 320: 1308-1311.
8. Schulz KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in randomized trials. Ann Intern Med 2002; 136: 254-259.
9. Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998; 317: 1185-1190.
10. Altman DG, Schulz KF, Moher D. Turning a blind eye - testing the success of blinding and the CONSORT statement [letter]. BMJ 2004; 328: 1135.
11. Aspirin Myocardial Infarction Study (AMIS) Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661-669.
12. Karloswki TR, Chalmers TC, Frenkel LD, et al. Ascorbic acid for the common cold. A prophylactic and therapeutic trial. JAMA 1975; 231: 1038-1042.
13. Beller EM, Gebski V, Keech AC. Randomisation in clinical trials. Med J Aust 2002; 177: 565-567.